Dermatology· Topic 3.8 Nodules and tumors of the skin· 3.8.13

Keloid

A keloid is a benign fibroproliferative scar that grows beyond the margins of the original wound and rarely regresses, treated first-line with intralesional triamcinolone acetonide 10-40 mg/mL every 4-6 weeks.

10 min read1 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Fibroproliferative scar that outgrows the wound: a benign dermal growth of disorganized, excess collagen that extends beyond the borders of the original skin injury, forming firm, raised, shiny…

  • Epidemiology

    Darker skin pigmentation: incidence is markedly increased in Fitzpatrick skin types IV-VI compared with lighter skin.

  • Risk factors

    Darker skin pigmentation: the single strongest risk factor.

  • Pathophysiology

    Excess TGF-beta drives fibroblast overactivity: aberrant TGF-beta signaling sustains fibroblast proliferation and collagen synthesis well beyond normal wound remodeling.

  • Clinical features

    Firm, raised nodule or plaque extending beyond the wound: the hallmark finding is scar tissue that has grown past the borders of the original injury, often with clawlike projections; this extension is what clinically defines a keloid.

  • Differential diagnosis

    Hypertrophic scar: stays confined within the original wound margin, arises earlier (within weeks of injury), and commonly regresses over months, versus a keloid, which extends beyond the wound, can…

  • Diagnosis

    Clinical diagnosis based on morphology and history: keloid is diagnosed clinically; the defining criterion is fibrotic tissue extending beyond the margins of the original wound, with a history of…

  • Management

    First line, intralesional triamcinolone acetonide 10-40 mg/mL: Small or thin papules: 5-10 mg/mL.

  • Complications

    Recurrence after treatment: common even with combined excision plus adjuvant therapy; excision alone carries a particularly high recurrence rate, often exceeding 50%.

  • Prognosis

    Rarely regresses without treatment: an untreated keloid continues to grow slowly over years rather than flattening spontaneously.

  • Prevention

    Avoid elective procedures at high-risk sites in a known keloid-forming patient: counsel against ear piercing, elective cosmetic surgery, and tattooing at the earlobe, shoulder, presternal chest, and jawline.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.